Key result
Captopril reduced mean supine blood pressure to 106/54 mm Hg at 24 hours in fluid-depleted anephric patients, compared to an increase to 134/82 mm Hg with placebo.
Why the study?
Does captopril reduce blood pressure in fluid-depleted and fluid-replete anephric patients?
RCT (n=7)
Double-blind
Cross-over
Does captopril reduce blood pressure in fluid-depleted and fluid-replete anephric patients?
Captopril lowers blood pressure in fluid-depleted anephric patients despite extremely low renin levels, suggesting its hypotensive effect does not depend solely on circulating renin.
Answers are grounded in this paper and cite their sources.
Supports captopril for BP control in fluid-depleted anephric patients; challenges renin-only mediation of ACE-inhibitor effects.
Randomised, double-blind cross-over trials were performed in seven anephric patients to determine the effect of the orally active angiotensin-converting enzyme inhibitor captopril on blood pressure in fluid-depleted and fluid-replete patients. Patients were given captopril, 100 mg orally, or placebo one hour after haemodialysis, when they were fluid depleted. Their mean (+/- SEM) supine blood pressure fell from 127 +/- 12/71 +/- 6 mm Hg before captopril to 106 +/- 13/54 +/- 4 mm Hg 24 hours after the drug, while on placebo it rose from 123 +/- 11/73 +/- 5 mm Hg to 134 +/- 10/82 +/- 8 mm Hg. All patients developed orthostatic hypotension after captopril. In the fluid-replete state, two days after haemodialysis, captopril had no effect on blood pressure. The plasma concentration of active renin was extremely low and did not rise after fluid withdrawal or captopril. Thus the hypotensive effect of captopril did not appear to depend on circulating renin concentrations. The concept of "renin-dependent" hypertension, which is responsive to captopril, as opposed to "volume-dependent" hypertension, which is not responsive to captopril, may therefore be invalid.
No takes yet. Share an insight, caveat, or question.
Veld et al. (1980) conducted an RCT in Anephric patients (n=7). Captopril vs. Placebo was evaluated on Supine blood pressure. Captopril reduced mean supine blood pressure to 106/54 mm Hg at 24 hours in fluid-depleted anephric patients, compared to an increase to 134/82 mm Hg with placebo.
Synapse has enriched 10 related papers. Consider them for comparative context: